MedTrace Logo

Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias

NCT05965375 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-04-04

No results posted yet for this study

Summary

The investigation of biomarkers for immune status and metabolic state, as well as host microbiota composition, in patients with ventricular arrhythmias before and after radiofrequency ablation, can provide new insights for specific and personalized treatment. This can help establish early prediction and prognosis models and provide a basis for clinically effective diagnosis and treatment.

Conditions

  • Ventricular Arrythmia

Interventions

OTHER

Observational; No Interventions were given.

Observational; No Interventions were given.

Sponsors & Collaborators

  • 521 Hospital of NORINCO Group

    collaborator OTHER

  • Shaanxi Provincial People's Hospital

    collaborator OTHER

  • Xiangyang Central Hospital

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Guoliang Li · First Affiliated Hospital Xi'an Jiaotong University

  • Chaofeng Sun · First Affiliated Hospital Xi'an Jiaotong University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2027-03-01
Completion
2027-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05965375 on ClinicalTrials.gov